Korean Biotech
- Korean Biotech's Four-Day Push at BIO USA 2026
Korean pharma and biotech firms used a packed four-day BIO USA 2026 schedule to court partners, from Kanaph Therapeutics to SK Biopharm and DXVX.
Korean pharma and biotech firms used a packed four-day BIO USA 2026 schedule to court partners, from Kanaph Therapeutics to SK Biopharm and DXVX.